RUNX2 and cancer: Figures 4A–C, 5A–C and 6A–C showed the percentages of RUNX1+ cells, CD8+RUNX1+T/CD8+T cells, CD103+CD8+RUNX1+T/CD8+T cells, RUNX2+ cells, CD8+RUNX2+T/CD8+T cells, CD103+CD8+RUNX2+T/CD8+T cells, RUNX3+ cells, CD8+RUNX3+T/CD8+T cells and CD103+CD8+RUNX3+T/CD8+T cells comparison between paracancer tissues and cancer tissues in CRC.